Cash Flow Statement

Daily Values

Growth Metrics

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)Income from Continuing Operations Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Profit After Tax Research & Development Selling, General & Administrative Shares Outstanding Shares Outstanding (Weighted Average)

Others

Ratios

Kalaris Therapeutics (KLRS) Selling, General & Administrative (2019 - 2020)